Strong Growth and Regional Performance Drive Buy Rating for Virbac SA

Valentin Paul Jahan, an analyst from Stifel Nicolaus, maintained the Buy rating on Virbac SA (0NM7 – Research Report). The associated price target remains the same with €390.00.

Valentin Paul Jahan has given his Buy rating due to a combination of factors that highlight Virbac SA’s strong performance and growth potential. The company’s recent sales figures for the first quarter of 2025 show a promising organic growth of 4.9%, which aligns with the expected trajectory to meet the annual growth guidance of 4-6%. This growth is particularly driven by robust performances in Europe and Latin America, where sales have increased by approximately 8%.
Despite challenges in the Australian market and moderate growth in the USA and Asia, the overall positive sales momentum supports the favorable outlook for Virbac. The companion and farm animal segments are performing well, with notable growth in the livestock sector in Europe. These factors, combined with a stable dividend yield and a significant upside to the price target, underpin the Buy recommendation for Virbac SA’s stock.